| Period Ending | Apr 29, 2013 | Jan 30, 2013 | Oct 30, 2012 | Jul 30, 2012 |
|---|
|
Total Revenue
|
1,080,653
|
1,174,584
|
1,128,866
|
1,135,414
| | Cost of Revenue | 704,918 | 803,491 | 725,264 | 729,343 | | |
Gross Profit
|
375,735
|
371,093
|
403,602
|
406,071
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 355,784 | 367,163 | 365,694 | 358,652 |
|
Non Recurring |
-
| 94,651 |
-
|
-
|
|
Others | 15,974 | 16,824 | 15,228 | 14,389 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
3,977
|
(107,545)
|
22,680
|
33,030
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 5,037 | 5,205 | 4,637 | 3,233 |
|
Earnings Before Interest And Taxes | 9,014 | (102,340) | 27,317 | 36,263 |
|
Interest Expense | 8,572 | 11,024 | 7,070 | 5,999 |
|
Income Before Tax | 442 | (113,364) | 20,247 | 30,264 |
|
Income Tax Expense | 11,306 | 27,992 | 7,378 | 10,047 |
|
Minority Interest | (1,554) | (1,467) | (2,321) | (1,334) |
|
|
|
Net Income From Continuing Ops | (12,418) | (142,823) | 10,548 | 18,883 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(12,418)
|
(142,823)
|
10,548
|
18,883
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(12,418)
|
(142,823)
|
10,548
|
18,883
|
|